Vir Biotechnology
Price & Volume
Stats
See moreOpen | $11.68 |
Previous Close | $11.22 |
Day Range | $11.17-$11.80 |
52W Range | $4.81-$12.19 |
Market Cap | $1.8B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $303.2M |
Revenue Growth (YoY) | 19,582.5% |
Gross Profit (12 Mos) | -$180M |
Diluted EPS | -$1.71 |
News
See moreYahoo Finance • 21 days ago
Vir Biotechnology, Gilead Sciences to Develop Dual-Masked T-Cell Engagers for Solid Tumors
Yahoo Finance • 21 days ago
Vir jumps on Gilead licensing deal worth up to $1.9B for cancer drugs
Yahoo Finance • 5 months ago
Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?
Yahoo Finance • 5 months ago
Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
About
CEO | Dr. Marianne De Backer M.B.A., M.Sc., Ph.D. |
CFO | Mr. Aziz Sawaf C.F.A., M.B.A. |
Address | 1800 Owens Street, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 367 |